Loading…

Which method should be chosen to estimate the oxygen cost of walking in post-stroke individuals?

•Oxygen cost provides access to the energy expenditure of walking in stroke individuals.•Oxygen cost can be estimated regardless of the method used to measure walking speed.•Estimation of the oxygen cost by gait speed has a good test retest reliability. The oxygen cost of walking (Cw) represents the...

Full description

Saved in:
Bibliographic Details
Published in:Gait & posture 2021-09, Vol.89, p.217-219
Main Authors: Compagnat, Maxence, Mandigout, Stéphane, Perrochon, Anaick, Salle, Jean Yves, Daviet, Jean Christophe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Oxygen cost provides access to the energy expenditure of walking in stroke individuals.•Oxygen cost can be estimated regardless of the method used to measure walking speed.•Estimation of the oxygen cost by gait speed has a good test retest reliability. The oxygen cost of walking (Cw) represents the energy expenditure involved in walking, which is a major concern when quantifying physical activity in stroke. Recent studies have reported that Cw may be estimated accurately with a prediction equation using the self-self-selected walking speed (Sfree). To evaluate the validity of Cw estimates according to different modalities of Sfree measurements (10-m walking test, 6-minute walking test, GaitRite system). Twenty-one stroke individuals in subacute phase who were able to walk without human aid were included. Cw was estimated from the walking speed measured during a 10-m walking test, a 6-minute walking test and a recording on a GaitRite system. The values of the Cw estimates were compared to those measured by a respiratory gas exchange analyzer (Metamax3b). The findings showed that there is no significant difference between the Cw measured by Metamax3b and the Cw estimates regardless of the modalities used to measure Sfree (Fvalue = 0.02; pvalue = 0.99). The mean bias between Cw measured by the Metamax3b and those estimated using the different Sfree measurement modalities was less than 2.5 % of the mean Cw value. Test retest reliability was excellent with an intraclass correlation coefficient higher than 0.95. in stroke survivors who are able to walk independently without human aid, the use of a 10-m walking test, a 6-minute walking test or a GaitRite recording can be considered validated for estimating Cw.
ISSN:0966-6362
1879-2219
DOI:10.1016/j.gaitpost.2021.07.017